• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Gudjon_Iceland

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Topics Started

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Sep 22
2:00 pm - 3:00 pm EDT

ALS Association Webinar: Affordable Tools for Everyday Independence

Sep 23
1:00 pm - 2:00 pm EDT

ALS Canada Webinar: Navigating Grief While Living with ALS

Sep 24
1:00 pm - 2:00 pm EDT

Les Turner ALS Foundation: Cognitive and Language Impairments in ALS & ALS-FTD

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

View Calendar

  • Jack Buzby, USA

    Jack Buzby, USA

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Frank Bos, Netherlands

    Frank Bos, Netherlands

  • Bayley, Australia

    Bayley, Australia

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Ann Nicol, USA

    Ann Nicol, USA

  • Wendy Hendrickson, USA

    Wendy Hendrickson, USA

  • Xian-Zhang Niu, China

    Xian-Zhang Niu, China

  • Jose Espinosa, Argentina

    Jose Espinosa, Argentina

  • Mike Cels, Canada

    Mike Cels, Canada

  • Frank Taylor, USA

    Frank Taylor, USA

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Paul Launer, USA

    Paul Launer, USA

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • John Dinon, Australia

    John Dinon, Australia

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Bob Simonds, USA

    Bob Simonds, USA

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Greg Heydet, USA

    Greg Heydet, USA

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login